Summit Clinical Research, LLC, a leading Integrated Research Organization (IRO) specializing in liver disease, obesity, and Alzheimer's Disease, announces the appointment of key senior leaders to drive the next phase of Summit's growth. Dr. Naim Alkhouri, MD, FAASLD, DABOM is a key opinion leader in the field of Metabolic Dysfunction-Associated Steatohepatitis (MASH) and joins Summit as Chief Academic Officer. This new role will lead Summit's medical & scientific functions, while perpetuating a focus on industry partnerships that advance drug development among these therapeutic areas. In addition to Dr. Alkhouri, Brandon Early, MS, joins Summit as President, leading all Summit functions and reporting to CEO & Co-founder Gail Hinkson.
"I'm thrilled with the arrival of these two leaders to generate a step-change in Summit's growth," said Gail Hinkson. "We've been fortunate to work with Dr. Alkhouri for years during his time at Arizona Liver Health. His experience treating patients and advancing drug development objectives with sponsor partners makes him an ideal leader for Summit. We look forward to this new role and the impact on our medical functions. In a complementary fashion, Brandon joins us from a long tenure of CRO leadership roles. He brings a level of operational rigor and customer partnerships to our unique IRO. Together these leaders are foundational to our continued growth."
"Summit is industry-unique for supporting both sponsors and sites," noted Dr. Alkhouri. "We've done excellent work in MASH drug development where Summit contributed an average of 30% of the sites per trial yet enrolled an average of 50% of the patients. There is a compelling opportunity to expand this impact into obesity and Alzheimer's Disease trials, and I look forward to this growth."
"I've followed Summit for years and witnessed their impact on many clinical trials," noted Mr. Early. "Summit supports clinical research sites and biopharma sponsors in a way that adds tremendous value to each. The industry needs better support mechanisms for sites to offset the shifts happening among large CROs: Summit offers high-science and hands-on support for our network sites."
Comments powered by CComment